Use of Genetically Altered Stem Cells for the Treatment of Huntington’s Disease

Author： Crane Andrew T.   Rossignol Julien   Dunbar Gary L.  

Publisher： MDPI

E-ISSN： 2076-3425|4|1|202-219

ISSN： 2076-3425

Source： Brain Sciences, Vol.4, Iss.1, 2014-03, pp. : 202-219

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuropsychiatric Burden in Huntington’s Disease

By Paoli Ricardo Augusto   Botturi Andrea   Ciammola Andrea   Silani Vincenzo   Prunas Cecilia   Lucchiari Claudio   Zugno Elisa   Caletti Elisabetta  

Brain Sciences, Vol. 7, Iss. 6, 2017-06 ,pp. : 67-67

MDPI

Access to resources Recommend Favorite

Striatal Vulnerability in Huntington’s Disease: Neuroprotection Versus Neurotoxicity

By Morigaki Ryoma   Goto Satoshi  

Brain Sciences, Vol. 7, Iss. 6, 2017-06 ,pp. : 63-63

MDPI

Access to resources Recommend Favorite

Use of Genetically Modified Mesenchymal Stem Cells to Treat Neurodegenerative Diseases

By Wyse Robert D.   Dunbar Gary L.   Rossignol Julien  

International Journal of Molecular Sciences, Vol. 15, Iss. 2, 2014-01 ,pp. : 1719-1745

MDPI

Access to resources Recommend Favorite

Effects of a Sativex-Like Combination of Phytocannabinoids on Disease Progression in R6/2 Mice, an Experimental Model of Huntington’s Disease

By Valdeolivas Sara   Sagredo Onintza   Delgado Mercedes   Pozo Miguel A.   Fernández-Ruiz Javier  

International Journal of Molecular Sciences, Vol. 18, Iss. 4, 2017-03 ,pp. : 684-684

MDPI

Access to resources Recommend Favorite

Deep Brain Stimulation in Huntington’s Disease—Preliminary Evidence on Pathophysiology, Efficacy and Safety

By Wojtecki Lars   Groiss Stefan Jun   Hartmann Christian Johannes   Elben Saskia   Omlor Sonja   Schnitzler Alfons   Vesper Jan  

Brain Sciences, Vol. 6, Iss. 3, 2016-08 ,pp. : 38-38

MDPI

Access to resources Recommend Favorite